Search Articles
Filter Articles
Found 2,756 articles
Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma
- 4 Dec 2023
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, including Advanced Therapy Medicinal Products (ATMPs), announced today that Dr. Günter Stempfer has been appointed Site Head of the company’s facility in Laupheim, Germany, effective December 1, 2023.
Thermo Fisher Scientific and Project HOPE Partner to Advance Health Equity Among HIV Positive Youth in Sub-Saharan Africa
- 4 Dec 2023
Thermo Fisher Scientific Inc., the world leader in serving science, and Project HOPE, a leading global health and humanitarian organization, today announced a new partnership to improve the wellbeing and treatment outcomes of adolescents and young persons living with HIV in Nigeria, the country with the second largest HIV epidemic worldwide.
How should I finish my job interview?
- 29 Nov 2023
Wrapping up your job interview on a strong note is crucial. Here are some steps to consider:
Stanhope and Cadillac Fairview appoint Morgan Lovell to build new lab space at White City Place for life sciences companies
- 29 Nov 2023
Stanhope and Cadillac Fairview today announce the appointment of Morgan Lovell to construct 24,000 sq ft of grow-on lab space in the MediaWorks Building at White City Place, due for completion in May 2024.
RetinAI Joins Forces with Stephen J. Ryan Initiative for Macular Research (RIMR) AMD Consortium to Forge a Global Retinal Imaging initiative Targeting Research in AMD
- 29 Nov 2023
RetinAI Joins Forces with Stephen J. Ryan Initiative for Macular Research (RIMR) AMD Consortium to Forge a Global Retinal Imaging initiative Targeting Research in AMD
-
EchoNous and United Medical Instruments (UMI) Join Forces to Accelerate Kosmos Growth in the USA
- 28 Nov 2023
EchoNous, a trailblazer in AI-enabled point-of-care ultrasound (POCUS) technology, is excited to announce a strategic partnership with United Medical Instruments (UMI), a leading ultrasound equipment provider with over two decades of expertise.
What should I do when I've been made redundant from my Life Science job?
- 28 Nov 2023
Being made redundant from a job, especially in a specialised field like Life Sciences, can be a challenging experience. However, it's also an opportunity to reassess your career path and explore new opportunities. Here are some steps you can consider
Alistair Henry – ‘On demand’ style service could transform diversity and inclusion in clinical trials - PharmiWeb
- 28 Nov 2023
UCB's Alistair Henry emphasizes easy access to UK clinical trials via digital tech, aiming for inclusivity and rich data. He highlights underrepresentation in trials and the role of technology in improving trial efficiency and patient experience.
Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus
- 28 Nov 2023
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing, today announces the appointment of Michel Spagnol as its new Chairman of the Board.
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
- 23 Nov 2023
Brainomix, the AI-powered medtech solutions company, has heralded its continued US expansion with the launch of its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care.
Mentice appoints Ulrika Drotz Voksepp as new Chief Financial Officer
- 23 Nov 2023
Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, appoints Ulrika Drotz Voksepp as CFO, effective January 2nd, 2024
Boris Bachmeier appointed new Managing Director of Romaco Pharmatechnik GmbH
- 23 Nov 2023
Boris Bachmeier has been appointed new Managing Director of Romaco Pharmatechnik GmbH in Karlsruhe. He succeeds Markus Regner, who will be leaving the company at his own request at the end of November.
8 Ways to Strengthen Your Employer Brand Through Thought Leadership
- 23 Nov 2023
Strengthening your employer brand through thought leadership is valuable for several reasons. Firstly, it will allow your organisation to establish itself as a trusted authority in the life science industry. You can position your company as a go-to source for industry knowledge and expertise by consistently sharing valuable insights, research findings, and thought-provoking content.
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
- 23 Nov 2023
Immutep (Formerly known as Prima Biomed) Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that the INSIGHT-003 trial has been expanded to four sites across Germany including the University Clinic of Ruhr Universität Bochum and the Lung Clinic Cologne-Merheim.
GSK announces major step towards sustainability ambitions with advancement of low carbon Ventolin programme to Phase III trials
- 21 Nov 2023
GSK plc (LSE/NYSE: GSK) today announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a next generation propellant, in 2024.
UK industry clinical trial performance shows signs of improvement, says ABPI report
- 17 Nov 2023
The decline in the number of industry clinical trials initiated in the UK shows welcome early signs of recovery. However, progress is not yet enough to restore the UK’s global ranking on trials.
Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments
- 17 Nov 2023
Today, the Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED, a co-developed, modernized, multi-stakeholder framework for sharing best practices of U.S. diverse clinical trial site leaders for inclusive cancer clinical trials.
Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
- 17 Nov 2023
AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN).
Roche launches automated serology hepatitis E virus tests, including a test to detect acute HEV infections, recommended in the new WHO 2023 Essential Diagnostics List
- 17 Nov 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the Elecsys®Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV) infections in countries accepting the CE mark. By testing for HEV infection, clinicians can support their patients to identify the cause of their symptoms and determine appropriate treatment, monitor for progression to severe acute HEV and prevent severe disease progression with antiviral treatment.
Results Published in The Lancet Show UBRELVY® (ubrogepant) Reduces the Headache Phase of a Migraine Attack When Dosed During the Prodrome of Migraine
- 17 Nov 2023
AbbVie (NYSE: ABBV) today announced detailed results published in The Lancet evaluating the efficacy, safety, and tolerability of UBRELVY® (ubrogepant) 100 mg for the acute treatment of migraine when administered during the prodrome of a migraine attack.
